Table 3. Toxicity outcomes—tests are by Wilcoxon rank-sum test except for *(log-rank test).
Toxicity |
DA |
DClo |
P-value | ||
---|---|---|---|---|---|
% grade 3–4 | Mean grade | % grade 3–4 | Mean grade | ||
Course 1 | |||||
Nausea | 5% | 0.8 | 10% | 1.0 | 0.01 |
Oral | 3% | 0.7 | 2% | 0.7 | 0.4 |
Diarrhoea | 12% | 1.1 | 8% | 1.0 | 0.12 |
Cardiac | 7% | 0.4 | 5% | 0.3 | 0.3 |
Liver AST | 6% | 0.6 | 6% | 0.5 | 0.6 |
Liver ALT | 4% | 0.6 | 6% | 0.7 | 0.3 |
Bilirubin | 7% | 0.8 | 5% | 0.7 | 0.04 |
Median days to neutrophil recovery | 20 | 24 | <0.0001* | ||
Median days to platelet recovery | 21 | 24 | <0.0001* | ||
Mean blood units | 11.0 | 9.5 | 0.0002 | ||
Mean platelet units | 12.9 | 9.8 | <0.0001 | ||
Mean days antibiotics | 19.7 | 16.7 | <0.0001 | ||
Mean hospitalisation days | 33.8 | 31.4 | <0.0001 | ||
Course 2 | |||||
Nausea | 4% | 0.7 | 7% | 0.9 | 0.004 |
Oral | 1% | 0.4 | 1% | 0.4 | 0.9 |
Diarrhoea | 4% | 0.6 | 9% | 0.7 | 0.19 |
Cardiac | 2% | 0.1 | 2% | 0.2 | 0.7 |
Liver AST | 1% | 0.2 | 4% | 0.4 | 0.06 |
Liver ALT | 3% | 0.4 | 2% | 0.6 | 0.004 |
Bilirubin | 3% | 0.5 | 5% | 0.4 | 0.4 |
Median days to neutrophil recovery | 20 | 21 | 0.2* | ||
Median days to platelet recovery | 25 | 24 | 0.3* | ||
Mean blood units | 6.3 | 6.4 | 0.9 | ||
Mean platelet units | 6.0 | 5.7 | 0.03 | ||
Mean days antibiotics | 9.4 | 9.6 | 0.6 | ||
Mean hospitalisation days | 25.0 | 23.4 | 0.01 |